Literature DB >> 21925225

Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.

Anne-Hélène Pillet1, Jacques Thèze, Thierry Rose.   

Abstract

Although interleukin (IL)-2 and IL-15 share the common signal transducing receptor chains IL-2Rβ and γ(c) and give rise to the same signaling patterns in human natural killer (NK) cells in vitro, they differ in their effects on the development, activation, and proliferation of these cells in vivo. We have previously demonstrated that the activation of NK cells induces a cellular program characterized by the sequential transcription-regulated expression of IL-15 and IL-2 high-affinity receptors. We demonstrate here that these receptors induce different responses. IL-15 sustains the expression of its high-affinity receptor, leading to long-lasting STAT5 phosphorylation and BCL2 expression. By contrast, IL-2 induces the rapid disappearance of IL-2Rα and γ(c) chains when the gene transcription is downregulated, shutting down IL-2-responses as demonstrated by the absence of STAT5 phosphorylation and BCL2 expression.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925225     DOI: 10.1016/j.humimm.2011.07.311

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  18 in total

Review 1.  Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens.

Authors:  Richard W Childs; Mattias Carlsten
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

2.  Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.

Authors:  Martin Felices; Todd R Lenvik; Dave E M Ankarlo; Bree Foley; Julie Curtsinger; Xianghua Luo; Bruce R Blazar; Stephen K Anderson; Jeffrey S Miller
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

Review 3.  Functions of IL-15 in anti-viral immunity: multiplicity and variety.

Authors:  Katherine C Verbist; Kimberly D Klonowski
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

4.  The effects of interleukin-2 on immune response regulation.

Authors:  Ryan S Waters; Justin S A Perry; SunPil Han; Bibiana Bielekova; Tomas Gedeon
Journal:  Math Med Biol       Date:  2018-03-14       Impact factor: 1.854

5.  Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.

Authors:  Jeffrey W Leong; Julie M Chase; Rizwan Romee; Stephanie E Schneider; Ryan P Sullivan; Megan A Cooper; Todd A Fehniger
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-13       Impact factor: 5.742

6.  Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma.

Authors:  Tomoyuki Tano; Masato Okamoto; Shin Kan; Koh-Ichi Nakashiro; Shigetaka Shimodaira; Shigeo Koido; Sadamu Homma; Mitsunobu Sato; Tomonobu Fujita; Yutaka Kawakami; Hiroyuki Hamakawa
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

Review 7.  Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.

Authors:  Joachim Koch; Michael Tesar
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

8.  Monocytes play an IL-12-dependent crucial role in driving cord blood NK cells to produce IFN-g in response to Trypanosoma cruzi.

Authors:  Aline Guilmot; Julie Bosse; Yves Carlier; Carine Truyens
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

Review 9.  Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.

Authors:  Rizwan Romee; Jeffrey W Leong; Todd A Fehniger
Journal:  Scientifica (Cairo)       Date:  2014-06-25

10.  Synergy between Common γ Chain Family Cytokines and IL-18 Potentiates Innate and Adaptive Pathways of NK Cell Activation.

Authors:  Carolyn M Nielsen; Asia-Sophia Wolf; Martin R Goodier; Eleanor M Riley
Journal:  Front Immunol       Date:  2016-03-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.